CNSP - Cns Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNSP is currently covered by 1 analysts with an average price target of $18.78. This is a potential upside of $12.61 (204.38%) from yesterday's end of day stock price of $6.17.

Cns Pharmaceuticals's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of CNSP is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 196 days.

Highest price target for CNSP is $20, Lowest price target is $20, average price target is $20.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 12-Sep-2025. First documented stock forecast 10-Sep-2024.

Best performing analysts who are covering CNSP - Cns Pharmaceuticals:

Jason Mccarthy

Currently out of the existing stock ratings of CNSP, 1 are a HOLD (50%), 1 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$20

$13.06 (188.18%)

3 months 15 days ago
(12-Sep-2025)

1/2 (50%)

$12.61 (170.64%)

196

Show more analysts

Please expand the browser size to see the chart

What is CNSP (Cns Pharmaceuticals) average time for price targets to be met?

On average it took 196 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on CNSP (Cns Pharmaceuticals) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on CNSP (Cns Pharmaceuticals)?

Jason Mccarthy works at MAXIM GROUP and has 0 price targets and 0 ratings on CNSP

Which analyst is the currently most bullish on CNSP (Cns Pharmaceuticals)?

Jason Mccarthy with highest potential upside - $13.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?